Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Duke Center for Human Systems Immunology is seeking a detail-oriented scientist to fulfill a key role as a Lab Research Analyst I. This individual will develop and perform assays to evaluate antibody
-
techniques. • Extraction of nucleic acids, conventional and quantitative PCR; nucleic acid electrophoresis. • Advanced handling of confocal microscope • Cell-labeling techniques with antibodies, ELISA
-
Screening Core within the Department of Host Microbe Interactions at St. Jude seeks a skilled and highly motivated candidate with experience in Antibody Discovery . This is a unique opportunity to join as an
-
for follow-up antibody design. Offering the right context and finding ways for experts to translate their domain knowledge into flexible and mineable formats for the recommender approach will be crucial
-
on mechanisms regulating the activation of cells of the immune system, cancer immunotherapy with the use of monoclonal antibodies, and effector cells including cells modified with chimeric antigen receptors (CAR
-
The Ignaz Semmelweis Institute (https://semmelweisinstitute.ac.at/) seeks applicants to fill five group leader positions. The Institute’s focus is basic and translational research in infectious
-
at the host-virus interface (http://starr.biochem.utah.edu ). Using a combination of computational, genetic, and biochemical approaches, we focus on how mutations in viral proteins and antibodies that bind them
-
of neutralising antibody responses following infection or vaccination; (iii) a proven track record of impactful research, publications, external grants and leadership; (iv) experience in teaching and postgraduate
-
of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics for the treatment of cancer and autoimmunity. This research has led
-
antibodies to support our own work as well as other researchers worldwide. Overall, the work of the lab is aimed to determine how anti-tumor immune responses can be harnessed for improved therapy outcomes